Cipla share price rises more than 3%: overhang of USFDA warning letter for its Pithampur facility still remains.
Stock Market Today - Cipla's Pithampur manufacturing facility receives warning letter. The facility remains important as exports of respiratory products such as Albuterol generics to the US are made form this facility.
Source: livemint.com